In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Baxter and Inhale Therapeutics agree to drug collaboration

Executive Summary

Baxter International and Inhale Therapeutic Systems (pulmonary drug delivery systems) signed a drug delivery agreement to use Inhale's dry-powder inhaler technology in a collaboration that could be worth $135 million to Inhale.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
Deal Status
  • Terminated
Deal Type
  • Alliance
    • R+D and Marketing-Licensing
    • Includes Equity

Related Companies

UsernamePublicRestriction

Register